Dr. Xavier Montalban is director of the Unit of Clinical Neuroimmunology, Vall d´Hebron University Hospital, Barcelona, a post he has held since 1990.
Dr. Montalban gained his MD in 1983 and was awarded a PhD in 1988, after formal training in neurology. In 1989 he undertook a postdoctoral research fellowship at Lupus Research Unit at St Thomas Hospital, London (UK), returning to Barcelona in 1990 to create the MS unit.
Dr. Montalban is a member of a number of scientific organisations, Patron of the Multiple Sclerosis Foundation, and sits on the Advisory Board and the Scientific Committee of the International Federation of Multiple Sclerosis Societies, European School of Neuroimmunology and the European Charcot Foundation. He is also a member of several editorial boards of both national and international specialist journals. He has published over 100 original contributions in international journals and has authored a number of book chapters. Since 2003 he is a member of the advisory committee on clinical trials of new agents, National Multiple Sclerosis Society, USA and since 2005 Member of the Scientific Committee of the European Federation of Neurological Societies (EFNS).
His current research interests include immune mechanisms in MS, cognitive dysfunction in MS, new intervention strategies and genetic characterization. He has published over 200 original contributions in international journals and has authored a number of book chapters. He has participated both in the design and execution of several phase II and phase III clinical trials, and is member of safety and steering committees.